The Centre has approached the Competition Commission of India the anti-monopoly regulator to probe whether global seed giant Monsanto Company’s India joint venture was charging higher-than-permissible royalties on its popular BT cotton seeds and, consequently, hurting farmers.
BT Cotton is India’s only genetically modified crop allowed for commercial cultivation. Monsanto does most of its business by sub-licencing its BT cotton technology to Indian seed manufacturers for a fee.
In a letter to the CCI, in which it sought a “detailed investigation” against the Maharashtra-based Mahyco-Monsanto Biotech Limited (MMB Ltd), the Radha Mohan Singh-headed farm ministry said it had got complaints against the firm related to “anti-competitive practices” and “unreasonable high prices” of BT Cotton seeds.
“We have not received any communication from the CCI. Should the CCI reach out to us for any clarification or information, we will extend our fullest cooperation,” a MMBL spokesperson said.
The agriculture ministry has requested a probe mainly against allegations that MMB Ltd could be abusing “its dominant position”, entering into sub-licence agreements that “appear to be anti-competitive” and “creating monopoly through restrictive agreement for unjust enrichment by charging higher trait value from its licensees and ultimately from farmers”.
The government wants probes into alleged predatory and anti-competitive behavior by the seed firm.
Full content: The Economic Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Turkey Hits Meta with $37.20 Million Fine Over Data-Sharing Practices
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI